Counsel for Torrent in Daliresp Hatch-Waxman Litigation

September 29, 2017

AstraZeneca and Takeda v. Torrent Pharmaceuticals Ltd.

Robins Kaplan LLP served as counsel for Torrent in Hatch-Waxman patent litigation in the District of New Jersey involving a number of patents related to COPD medication Daliresp (roflumilast). The parties entered into a consent judgment on September 29, 2017.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.

Similar Results

Back to Top